Peripherally acting M-opioid receptor antagonists can improve quality of life but differ variably by impact from concomitant medications.
Amelia L. Persico, Pharm D, MBA
Advertisement
Articles by Amelia L. Persico, Pharm D, MBA
Advertisement
Latest Updated Articles
Toxicity Is a Risk of PAMORA InteractionsPublished: July 1st 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
2
A Review of Antibody-Drug Conjugates for the Treatment of Urothelial Carcinoma: The Rise of Enfortumab Vedotin
3
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
4
Low-Dose Aspirin Linked to Lower Cardiovascular Risk in Type 2 Diabetes
5
